 | Cerevel Therapeutics Holdings, | |||
| NasdaqCM : CERE || Location: United States | ||||
$32.785+0.78 (+2.45%) |
0.28 M | 31.755 - 33.37 | ||
| Last Updated:08/17/2022 12:27 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 29, 2022 | 5.085 M |
| July 15, 2022 | 5.836 M |
| June 30, 2022 | 6.084 M |
| June 15, 2022 | 5.362 M |
| May 31, 2022 | 4.892 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2022 | -0.48 | -0.62 | -29.20% |
| 03/31/2022 | -0.42 | -0.46 | -9.50% |
| 12/31/2021 | -0.41 | -0.40 | 2.40% |
| 09/30/2021 | -0.40 | -0.43 | -7.50% |
| 06/30/2021 | -0.39 | -0.42 | -7.70% |
CERE Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 148.502M | Shares Float | 60.310M |
| Short Float | 5.085M | Market Cap | 5112.92M |
| Institution ownership | 84.30% | Insider ownership | 18.553% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -1.71 | Forward EPS | -2.54 |